Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents-Reference-Cited by-同舟云学术

Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents

Published:2013-07 Issue:7 Volume:11 Page:826-831
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Kestens Christine,van Oijen Martijn G.H.,Mulder Charlotte L.J.,van Bodegraven Ad A.,Dijkstra Gerard,de Jong Dirk,Ponsioen Cyriel,van Tuyl Bas A.C.,Siersema Peter D.,Fidder Herma H.,Oldenburg Bas

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Inflammatory bowel disease therapy: current state-of-the-art;Blonski;Curr Opin Gastroenterol,2011

2. American Gastroenterological Association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006;Clark;Gastroenterology,2007

3. Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approach;Etchevers;Drugs,2010

4. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

5. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial;Colombel;Gastroenterology,2007

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How comparative studies can inform treatment decisions for Crohn’s disease;Expert Opinion on Biological Therapy;2024-08-12

2. Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies;Expert Opinion on Biological Therapy;2024-02-23

3. Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions;Clinical and Experimental Gastroenterology;2023-12

4. Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?;Digestive and Liver Disease;2023-12

5. Comparison of Clinical Outcomes in Pediatric Patients with Ileocolonic Crohn Disease Treated with Infliximab Versus Adalimumab;Journal of Pediatric Gastroenterology & Nutrition;2023-06-05